Listening to a favorite song can trigger a profound emotional response that rivals the feelings produced by biological ...

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar ...

The daily pill may provide a more convenient alternative to injections, which patients can find difficult to administer.

An international research group directed by UMC Utrecht has developed and characterized two first-in-class antibodies that ...

In their new study, the LJI scientists are the first to show that GPR25 is induced by a signaling molecule called TGF-β.

Scientists discovered that lowering a specific molecule helps microglia switch into a protective state that quiets brain ...

A rare intracranial brain-recording study revealed that tirzepatide, a GLP-1 and GIP receptor agonist, temporarily silences craving-related neural activity in a key reward circuit of the brain.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

In Alzheimer’s disease, which is the most common cause of dementia, microglia (the immune cells of the brain) can behave in very different ways. At times, they help protect the brain, and at other ...

Purdue Pharma LP won court approval to exit bankruptcy, capping six years of legal wrangling over a multibillion-dollar ...